Institutional Biosafety Committee (IBC)

IBC Policies and Procedures

Below, find the current IBC Policies and Procedures, or download a copy of the IBC Policies and Procedures Document.

Section 1: Introduction
Section 2: Responsibilities
Section 3: Protocol/Modification Submission and Review
Section 4: Meeting Process 
Section 5: Reporting Requirements
Section 6: Non-Compliance 
Section 7: Training
Section 8: Occupational Health Services Program - Laboratory Animals and Biomedical Services (OHPLABS)
Section 9: Record Retention Policy at The University of Texas at Austin

IBC Protocol Review Process and Meeting Dates

Protocols undergo a pre-review that includes an assessment for completeness and confirmation of content before being sent to the committee for review. Once a protocol is complete and pre-review questions have been answered, it is scheduled on a committee agenda.

Complex protocols such as those describing multiple aims, RG-2 vectors, pathogenic agents or novel procedures and technology should be submitted at least four weeks prior to the next committee meeting. Researchers are encouraged to split complex projects, especially those with multiple aims, into additional protocol(s) to facilitate a faster review process.

If funding is pending IBC approval, email IBC@austin.utexas.edu. IBC personnel will help facilitate the protocol submission, review and approval process.

Meetings held may be open to the public, when consistent with protection of privacy and proprietary interests. Please email IBC@austin.utexas.edu at least two weeks in advance to facilitate arrangements.

Meeting Dates

At the discretion of the IBC, scheduled meeting dates may change or additional meeting dates may be added to the schedule.

Scheduled IBC Meeting Dates Submission Date
December 9, 2025 November 18, 2025
January 27, 2026 January 6, 2026
March 3, 2026 February 10, 2026
April 7, 2026 March 17, 2026
May 12, 2026 April 21, 2026
June 9, 2026 May 19, 2026
July 28, 2026 July 7, 2026
September 8, 2026 August 18, 2026
October 13, 2026 September 22, 2026
November 10, 2026 October 20, 2026
December 8, 2026 November 17, 2026

IBC Fees 

IBC issues fees for protocol review, amendment and closure. These fees should be considered when writing proposals. Fees are assessed in the following situations:

  • Industry sponsored clinical trials submitted for review and approval by the IBC
  • Research requiring IBC approval conducted in UT facilities on behalf of non-UT institutions when there is no award to UT
IBC Action Fee
Initial Convened IBC Review $2,500
Tri-Annual Renewal Review $2,500
Amendment Review $700
Closure $100

IBC Minutes

This is a new requirement starting June 1, 2025

According to the NIH memo Implementation Update: Promoting Maximal Transparency Under the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules, starting June 1, 2025, the NIH expects that approved meeting minutes from all IBC meetings occurring on, or after this date will be posted publicly on an institutional website. It is NIH's expectation that minutes will be posted immediately after approval and once all appropriate and allowable redactions have been made. Please note that the provisions of this memo only apply to meetings taking place on, or after June 1, 2025. Minutes from meetings before that date do not need to be posted but still must be provided to members of the public upon request.

 

IBC Contacts

Questions?
Send all IBC-related matters to the Biosafety Compliance office.
IBC@austin.utexas.edu
512-471-8871

Ryan Gray, Ph.D.
IBC Chair, College of Natural Sciences
ryan.gray@austin.utexas.edu

Enamul Huq, Ph.D.
IBC Vice-Chair, College of Natural Sciences
huq@austin.utexas.edu

Questions?

Send all IBC-related matters to the Biosafety Compliance Office at IBC@austin.utexas.edu or call 512-471-8871

On this page: